Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study

Abstract Background Microvascular invasion (MVI) is considered to be one of the important prognostic factors that affect postoperative recurrence in patients with hepatocellular carcinoma (HCC) with variable results across their treatment options. This study was carried out to investigate efficacy o...

Full description

Bibliographic Details
Main Authors: Liming Wang, Weihu Wang, Weiqi Rong, Zhuo Li, Fan Wu, Yunhe Liu, Yiling Zheng, Kai Zhang, Tana Siqin, Mei Liu, Bo Chen, Jianxiong Wu
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Microvascular invasion
Radiotherapy
Relapse survival
Overall survival
Online Access:http://link.springer.com/article/10.1186/s12885-020-07087-7

Internet

http://link.springer.com/article/10.1186/s12885-020-07087-7

Similar Items